background: Early embryo development (EED) forms the basis of assisted reproductive technologies (ARTs), which are used to treat human infertility and to propagate other mammalian species. Thyroid hormones (THs) play an important role in the post-implantation development of the embryo in mammals; however, the effects of THs on pre-attachment embryos are not known. Currently utilized in-vitro embryo production media are devoid of THs and hence our main objective was to examine whether THs affected EED in a bovine model.
Introduction
Assisted reproductive technologies (ARTs) are biology-based procedures designed to enhance fertility. In human beings, ARTs are used as an infertility treatment whereas in domestic, laboratory and endangered animal species, they are primarily employed to propagate genetically valuable individuals. Over the last 50 years numerous studies have been directed towards the development of new technologies for the production of embryos in vitro (Clarke, 2006) . Indeed, over 8 million children have been born as a result of in-vitro fertilization (IVF) since 1978 (Hartshorne, 2008) . The cattle industry is the biggest of the livestock industries and is an important contributor to the gross national product of many countries; over 265 000 in-vitro produced embryos are transferred to surrogate recipients each year (Thibier, 2006) . Despite the widespread use of ARTs, the efficiency of in-vitro embryo production methods, as evidenced by the pregnancy rates, remains rather low; 25-30% in humans (Wunder et al., 2005) and 60% in cattle (Hasler, 2001) . Much of our knowledge of ARTs has been derived from human clinical trials and studies using a variety of animal models including the domestic cow. Regarding in-vitro embryo production, main research goals often include the increased formation rate and viability of blastocysts, as this particular stage of development represents the point where embryos are usually transferred to recipient females or cryopreserved. The developmental competence is still less for in-vitro produced embryos compared with the in-vivo derived ones (Galli et al., 2003; Mastromonaco et al., 2004) .
The pre-hatching period of mammalian embryo development, i.e. early embryo development (EED), involves several timely and precise cellular and molecular processes that must occur subsequent to the fusion of the male and female gametes. The media are one of the key components of in-vitro embryo production and play an important role in supporting proper cellular physiology and gene expression, which ultimately ensure normal post-implantation development (Lane and Gardner, 2007) . Ideally, the in-vitro environment for EED should simulate physiological conditions as closely as possible. Thyroid Hormones (THs) are known to be essential regulators of post-implantation embryo development (Ohara et al., 2004) . THs have been detected in follicular fluid of several mammalian species (Slebodzinski, 2005) including humans (Wakim et al., 1993) . Recently, we have described changes in systemic and ovarian follicular fluid levels of THs at different reproductive states in cattle (Ashkar et al., 2009 ). However, currently there is a trend towards excluding biological substances from the in-vitro embryo production systems to develop chemically defined media. Therefore, these media do not contain THs despite numerous publications supporting the role of the hormones in early pregnancy (Obregon et al., 1984; Ohara et al., 2004; Oki et al., 2004) .
The objective of the present study was to determine if THs would enhance the development and ameliorate the cryopreservation of in-vitro produced bovine embryos. Our first goal involved determining whether or not THs are present at the site of EED in vivo (i.e. the oviduct and uterine horn). Next, we wanted to examine the effects of THs on early bovine embryo development in vitro. To identify the specific stage at which THs exert their effects, THs were added to different media [i.e. in-vitro maturation (IVM), IVF and/or culture (IVC) media]. Lastly, the embryonic cell counts and apoptotic rates as well as the post-cryopreservation hatching ability were assessed and compared between TH-supplemented and untreated embryos.
Materials and Methods

Chemicals
All chemicals where purchased from Sigma-Aldrich chemical company (Oakville, ON, Canada) unless otherwise stated.
Preparation of oviducts and uterine horns for TH assays
Reproductive tracts from five cows were collected at necropsy and transferred immediately to the laboratory. The oviducts were dissected free from connective tissue using a scalpel and the weight of each oviduct was recorded. As a minimum sample volume of 1 ml was required for TH analyses, each oviduct was flushed with 1.5 ml of saline and effluent was collected to a glass tube. To investigate the presence of THs in oviductal tissue, the oviducts were homogenized and, to obtain sufficient sample volume, 1 ml of saline was added prior to homogenization of oviductal tissue. Homogenized oviducts were centrifuged for 10 min at 3000 rpm and the supernatant was collected. One third of the uterine horns adjacent to the oviduct were dissected and flushed with 3 ml of saline. In addition, to measure the concentrations of THs in the endometrial layer, each uterine horn was cut open with a scalpel, and the endometrium was scraped and placed in 10-ml centrifuge tubes. Saline (0.5 ml per sample) was added to the scraped tissue, the mixture was centrifuged, and supernatants were collected as described for the oviductal tissue above.
Experimental design
Bovine oocytes collected post-mortem were subjected to a standard IVF protocol. Thyroid hormones (T 3 -triiodothyronine and T 4 -thyroxine) were added to the media at different time points. Approximately 1800 oocytes were used for IVM, IVF and IVC procedures in this study, for the control and TH-supplemented groups (50 ng/ml of FT 3 and 50 ng/ml of FT 4 ), to determine the effects of THs added to each media on EED. Cleavage rate was evaluated on Day 2, blastocyst rate on Day 8 and hatching rate on Day 9 post-insemination. To determine the timing of the effects of THs on embryo development, we conducted 13 independent trials involving over 3200 oocytes and followed them from IVM to IVC where either IVM or IVC media only were supplemented with THs. Blastocysts were harvested on Day 8 for either cryopreservation or TUNEL assays.
In-vitro embryo production Domestic cattle (Bos taurus) ovaries were collected from a government inspected abattoir (Guelph, ON, Canada). Oocytes were aspirated and subjected to IVM, IVF and IVC as previously described by Mastromonaco et al. (2006) and Favetta et al. (2007) . In brief, cumulus-oocyte complexes (COCs) were collected from visible ovarian follicles by aspiration into HEPES-buffered Ham's F-10 plus 2% steer serum (Cansera; Rexdale, ON, Canada). Oocytes with several layers of cumulus cells and homogenous cytoplasm were then randomly assigned into control and treated groups. COCs were matured in 80-ml drops of TCM199 medium þ 2% steer serum (IVM) supplemented with 1 mg/ml of estradiol, 0.5 mg/ml of bFSH and 1 mg/ml of bLH (NIH, Washington, DC, USA) (IVM þ H) under silicone oil (Paisley Products, Scarborough, ON, Canada) for 20 -22 h at 38.58C in 5% CO 2 in air. The media used for treated groups were supplemented with 50 ng/ml of both FT 3 and FT 4 . Co-incubation with sperm was carried out in 80-ml drops of IVF TALP under silicone oil (Paisley Products, Scarborough, ON, Canada) for 18 h at 38.58C in 5% CO 2 in air. Frozen-thawed sperm was prepared by swim-up in 5 ml of sperm TALP and centrifugation at 2000 rpm for 10 min. The oocytes were inseminated with a final concentration of 1 Â 10 6 motile frozen-thawed sperm/ml (Gencor, Guelph, ON, Canada).
After 18 -20 h, the presumptive zygotes were stripped of remaining cumulus cells by vortexing and cultured in 30-ml drops of synthetic oviductal fluid (SOF) (Chemicon-Millipore, Billerica, MA, USA) plus 200 ml of non-essential amino acids, 100 ml of essential amino acids (Invitrogen), 5 ml of gentamicin (Invitrogen), 560 ml of EFAF BSA 15% in SOF and 200 ml of bovine steer serum under silicone oil at 38.58C in 5% CO 2 , 5% O 2 , 90% N 2 for 9 days.
Apoptosis and total cell number analyses
The terminal deoxynucleotidyl transferase mediated dUTP nick-end labeling (TUNEL) assay (Roche Diagnostics, Indianapolis, IN, USA) was carried out as described previously by Matwee et al. (2000) , Gjorret et al. (2003) and Mastromonaco et al. (2007) . Briefly, expanded blastocysts from both treated and control groups, exhibiting the stage-specific morphology and similar size, were washed separately several times in PBS containing 0.3% polyvinyl alcohol (PBS-0.3% PVA) in 4-well dishes and fixed in 4% paraformaldehyde for 1 h. Prior to staining, the embryos were washed several times in PBS-0.3% PVA to remove any traces of paraformaldehyde. Embryos were then permeabilized by incubation in 0.5% Triton X-100 for 1 h and further incubated with fluorescein isothiocyanate (FITC)-conjugated dUTP and terminal deoxynucleotidyl transferase (TdT) enzyme for 1 h at 378 in the dark, treated with 50 mg/ml RNase at room temperature for 1 h, and counterstained with 40 mg/ml propidium iodide (PI) for 1 h at 378. Along with control and treatment groups, positive and negative controls were processed. For the positive controls, embryos were incubated in DNase solution (2 ml of DNase þ 38 ml of PBS þ PVA) for 20 min in a humidified chamber at 378. For negative controls, only the label (FITC) was added, whereas all test samples Thyroid hormones and early bovine embryo development and positive controls were treated with the label and enzyme (TdT). Finally, embryos were washed in PBS-0.3% PVA and mounted on a slide using Vectashield anti-fade solution (Vector Laboratories, Burlingame, CA, USA). Analysis of TUNEL staining was carried out at 40Â image magnification using a Leitz fluorescence microscope. Two nuclear parameters were assessed to define apoptotic morphology: (i) changes in nuclear morphology (condensation) and (ii) FITC staining of fragmented DNA, which in nuclear morphology appears as a yellowish color by overlaying red and green stain. Apoptosis rates were expressed as the fraction of fragmented nuclei relative to total nuclei counts in each blastocyst from both treated and untreated groups. Also, total cell number for each blastocyst in both groups was determined by counting red nuclei. A total of 174 expanded blastocysts were examined with the TUNEL assay and used to enumerate the embryonic cells (Fig. 1 ).
Cryopreservation
On Day 8 post-insemination, expanded blastocysts were cryopreserved by a standard slow freezing protocol (Hochi et al., 1996) . The embryos were processed and frozen in commercially available cryopreservation media, Vigro Ethylene Glycol Plus (Bioniche Life Sciences Inc., Belleville, ON, Canada) as follows: straws (0.25 ml) were loaded with one long column of Vigro Holding Media Plus and one short column of Vigro EG. Embryos were transferred from their original culture drops and rinsed in holding media, then placed in a 35-mm dish containing 2.5 ml of Vigro EG. Embryos were aspirated into a second drop of EG within the straw. A final volume of holding medium was drawn up into the straw that was then heat-sealed. Within 10 min of exposure to EG, embryos were placed into the alcohol bath of an FTS programmable freezer, previously equilibrated to 278C, and cooled at a rate of 0.38C per minute to 2358C. After the program was completed, the straws were plunged into liquid nitrogen for storage from 1 h up to several days. To assay the survival rates, the straws were thawed rapidly for 5 s in air followed by 15 s in a 358C water bath. Thereafter, all steps were carried out in warm (30-358C) media. The content of the straw was expelled into an empty Petri dish. The embryos were collected and washed in Vigro Holding media, and subsequently in embryo culture media (SOF). Embryos from both control and treated groups were then placed into drops of culture media and evaluated for post-cryopreservation survival (Farin et al., 1995) . The end-points assessed were the blastocyst re-expansion by 24 h after thawing and, at 72 h post-thawing, the survival rate and hatching ability.
TH assays of oviduct and uterine horn tissue samples and of IVC media
Thyroid hormone levels were measured by validated radioimmunoassays (RIAs) in the Diagnostic Center for Population and Animal Health, Michigan State University, USA, and as described previously (Ashkar et al., 2009) . The sensitivity of the total T 4 assay was 3 nmol/l and the intra-and inter-assay coefficients of variation (CVs) were ,10%. The assay for estimating free T 4 (FT 4 ) levels utilized a highly specific low affinity monoclonal antibody to T 4 . The assay was performed in two steps; the first incubation was with the sample in contact with solid phase T 4 antibody at 378C for 30 min. The serum was then decanted and the second incubation was with the 125 I-T 4 in buffer. The 125 I-T 4 fills any remaining solid phase antibody sites so that the amount of bound radiation is inversely proportional to the amount of FT 4 in the serum. Sensitivity of the assay was determined to be 3 pmol/l using the 90% of specific binding (B/B 0 ) end-point. The intra-assay CVs for control Figure 1 Protocol for apoptosis and total cell number analyses using terminal deoxynucleotidyl TUNEL assay. FITC-conjugated dUTP and TdT enzyme were used to detect DNA fragmentation and cell nuclei were counterstained with propidium iodide (PI). Yellow staining in the overlain images of the positive controls and test samples (right panels) indicates DNA fragmentation (positive controls) or apoptotic cells (test).
samples with mean FT 4 concentrations of 8, 16 and 33 pmol/l were 7, 5 and 5%, respectively. The inter-assay CVs for control samples with mean hormone concentrations of 7, 14 and 32 pmol/l were 13, 10 and 14% at, respectively. The assay for TT 3 was an 'in house' 125 I RIA method using activated charcoal in the separation step. The intra-and inter-assay CVs for the assays are all less than 10%. Sensitivity of the TT 3 assay is 0.25 nmol/l. The assay for estimating FT 3 used a 125 I-triiodothyronine (T 3 ) derivative that does not bind significantly to the natural binding proteins in serum. In addition, a high affinity antibody was used that binds both the derivative and T 3 . Sensitivity was determined to be 1.2 pmol/ l at 90% B/B 0 . The intra-assay CVs were 14, 14 and 6% at FT 3 concentrations of 3, 6 and 13 pmol/l, and the inter-assay CVs were 14, 20 and 14% at hormone concentrations of 2, 4 and 11 pmol/l, respectively.
Statistical analyses
Non-parametric procedures through Wilcox on Scores (rank sums) test and Fisher exact test in SAS (Statistical Analysis System) program were used to analyze the differences in the cleavage rate, blastocyst formation rate, hatching rate, apoptosis rate, total cell numbers and postcryopreservation viability of embryos between control and treatment groups. All values were expressed as means + SEM. All differences were considered as significant when the P-value was ,0.05.
Results
Thyroid hormones were present in bovine oviducts and uterine horns
The levels of THs in uterine horn and oviductal flushings were not detectable; however, THs were detected in the homogenate of oviduct and uterine horn tissue (Table I) .
TH supplementation with different doses was not associated with reduced cleavage, blastocyst and hatching rates
We supplemented all three media (IVM, IVF and IVC) with the three different doses of both FT 3 and FT 4 , namely 10, 50 and 100 ng/ml. Addition of THs had no adverse side effects on embryo development as compared with the controls without THs. In the three trials using the ascending doses of THs, there were only numerical, but not significant, differences in the cleavage rate, blastocyst formation rate and hatching rate (Table II) .
Supplementation of IVC media alone improved EED
There were no significant differences (P ¼ 0.20) between control and treatment groups with respect to cleavage rates. Approximately 83% of oocytes cleaved in the control groups as compared with 87% in the treatment groups ( Fig. 2A and B) . However, the blastocyst formation rate on Day 8 was greater (P , 0.05) in the treated group as compared with control ( Fig. 2C and D) . Also, the hatching rate was higher (P , 0.05) in the TH-supplemented group ( Fig. 2E and F) . When only IVM media were supplemented with THs, no statistical difference in the mean cleavage rate (P ¼ 0.20; Fig. 3A and B) and blastocyst formation rate (P ¼ 0.50; Fig. 3C and D) was observed between the treated and control embryos. Data analysis for the embryos developing in IVC supplemented media demonstrated a significant (P , 0.01) increase in the blastocyst formation rate as compared with untreated controls (Fig. 3G and H) . However, the cleavage rate did not vary between the two groups ( Fig. 3E and F Both THs were added in equal amounts to the IVM, IVF and IVC media used in three consecutive trials.
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Embryo quality was improved after addition of THs
Blastocysts supplemented with THs had higher total cell numbers (P , 0.01; Fig. 4A and B) and the numbers of apoptotic cells in treated blastocysts was lower than that in the control group (P , 0.01; Fig. 4C and D) .
Post-cryopreservation embryo viability was significantly enhanced by TH supplementation
All 198 blastocysts from the treated group and all 152 blastocysts from the control group exhibited re-expansion of the blastocoelic cavity and Oocytes/embryos were subjected to IVM, IVF and IVC media with or without FT 3 and FT 4 (both hormones at 50 ng/ml-treatment groups); (C) Blastocyst formation rates by replicate; (D) Mean + SEM blastocyst formation rates; (E) Percentages of hatched blastocysts by replicate; (F) Mean + SEM percentages of hatched blastocysts. The numbers of matured oocytes used (A), blastocysts formed (C) and hatched (E) are given in the upper bar area. *P , 0.05. Only the maturation media (IVM) in the treated group were supplemented with THs (FT 3 and FT 4 ; both 50 ng/ml); (C) Blastocyst formation rates by replicate; (D) Mean + SEM blastocyst formation rates; (E) Cleavage rates by replicate; (F) Mean + SEM cleavage rates. FT 3 /FT 4 were added only to IVC media; (G) Blastocyst formation rates by replicate; (H) Mean + SEM blastocyst formation rates. The numbers of matured oocytes used (A and E) and blastocysts formed (C and G) are given in the upper bar area. **P , 0.05.
Thyroid hormones and early bovine embryo development these were considered to be the viable post-cryopreservation embryos. There was a greater higher rate in the treated group as compared with the control (P , 0.05; Fig. 5A and B) . From 198 re-expanded blastocysts in the treated group, 84 hatched, whereas in the control group only 57 of 152 blastocysts hatched (P , 0.05; Fig. 5C and D).
Only 60% of the amount of THs added were bioavailable to developing embryos
When both the freshly prepared and post-incubation samples of supplemented IVC media were assayed for TH levels, 60.5% of T 4 was bioavailable, and 57.4% of T 3 was bioavailable in the fresh supplemented IVC media, whereas in the incubated samples, 59.2 and 58.1% of T 4 and T 3 were bioavailable, respectively.
Discussion
A wealth of information concerning contemporary ARTs has been derived from studies using the bovine model (Lane and Gardner, 2007) . The gestational period is similar in both human beings and cattle. The number of oocytes released in each ovulatory cycle is also similar and since there is typically a single fertilization, the number of offspring is the same. Further, the chronology and rates of in-vitro embryo development are strikingly similar in both species. Lastly, ovarian follicular dynamics and TH follicular fluid levels are similar in both species (Slebodzinski, 2005; Blaszczyk et al., 2006; Ashkar et al., 2009) . Therefore, the bovine model to study the effects of THs on EED can be effectively used as an experimental model for human situation and the results may be extrapolated to humans and several other mammalian species. TH influences are ubiquitous in vertebrates. It is therefore not surprising that these hormones are present in the reproductive system and may impinge on normal reproductive function. However, although other investigators have demonstrated the presence of THs in different mucosal fluids (DeGroot and Jameson, 2006) , and various blood serum components and endocrine factors have been studied in the fallopian tube fluid and uterine endometrium of different mammalian species (Libersky and Boatman, 1995; Tay et al., 1997; Harris et al., 2005) , there has been no study of THs in oviductal or uterine structures. Therefore, it was imperative that our study began with assaying TH levels in these structures. In this study, THs were detected in the homogenate of the bovine oviduct and endometrium (Table I ). Although optimization of in-vitro embryo production requires an environment that simulates physiological conditions closely, currently used in-vitro embryo production media are devoid of THs. The present study clearly demonstrated that supplementation of IVC media improved the EED rate, embryo quality and postcryopreservation competence in the bovine model. The first three trials showed numerical increases in developmental rate of embryos treated with 50 ng/ml (Table II) .
We have previously determined the blood serum concentrations and follicular fluid content of the free fractions of THs in cows under different physiological conditions (Ashkar et al., 2009) . However, in the present study, we opted to use supplementation doses that exceeded physiological FT 4 and FT 3 concentrations, since THs are known to bind to serum albumin and pre-albumin as well as transthyretin in mammalian species (Baudry et al., 1978; Larsson et al., 1985; Robbins, 2002) , and these interactions effectively reduce the free fraction of THs. As bovine serum albumin is added to the IVC media, increasing TH concentrations in the present study reduced the influence of these interactions.
Furthermore, THs bind to surfaces of plastic culture dishes thereby further reducing the bioavailability of free TH fractions in the media (Stankovic and Parmar, 2006) ; this obstacle was also addressed by increasing TH concentrations. Considering all of these factors, we chose to use in-vitro concentrations similar to those in previously published studies (Marruo et al., 1991; Jiang et al., 1999; Oki et al., 2004) . Despite the use of supraphysiological TH concentrations, inconsistencies in dose-response were evident (Table I) , and these may have been the result of unanticipated chelation of THs in the media. Only 60% of the administered doses were detected in the media post-treatment. Therefore, to achieve bioavailable concentrations of THs comparable to physiological levels, it seems that supplementation with at least twice the target concentration is required. Further characterization of the dose-response relationship is also needed as is the study of individual and combined effects of T 3 and T 4 (free fractions).
TH supplementation at the dose of 50 ng/ml significant increased the blastocyst formation and hatching rates. TH supplementation did not alter cleavage or fertilization rates. Blastocyst hatching rate is an Figure 5 A summary of post-thawing embryo survival rates: (A) Percentages of embryo survival following thawing by replicate; (B) Mean + SEM embryo survival percentages post-thawing. Day 8 bovine embryos (blastocysts; both treated and control groups) were harvested and frozen in liquid nitrogen under a slow freezing protocol. Embryo survival rate post-cryopreservation was evaluated 24 h after thawing the cultured embryos from pre-conditioned IVC media; (C) Hatching rate percentages by replicate; (D) Mean + SEM hatching rate percentages post-thawing. The hatching rates were calculated 72 h after cryopreserved embryos were cultured in pre-conditioned IVC media. The numbers of frozen embryos evaluated (A) and of hatched blastocysts (C) are given in the upper bar area. *P , 0.05.
Thyroid hormones and early bovine embryo development important indicator of embryo quality, especially for the transfer of in-vitro and in-vivo produced embryos to ensure that implantation can occur. Interestingly, there is a paucity of studies investigating the role of THs in embryo hatching. Since our findings show an increase in hatchability of blastocysts in the presence of THs, this study is the first to demonstrate the importance of THs in maximizing in-vitro blastocyst hatching rate. Early bovine embryo development in the presence of serum-supplemented media was associated with increased blastocyst formation and hatching rates as compared with the serumfree (BSA-based) media (Mastromonaco et al., 2004) . Since we have shown that supplementation specifically with THs produced a similar result, it is attractive to speculate that THs play an important role in EED and constitute an integral component of serum-derived factors that may enhance embryo competence in vivo and in culture media.
In the present study, there was no difference in embryo development between control and treated groups when only IVM media were supplemented with THs. However, IVC media supplementation resulted in a significantly increased blastocyst formation rate. Embryos subjected to media in which only IVC media were supplemented, were not available for further evaluation. Thus, the hatching rate following this specific treatment should be evaluated in future. Nevertheless, these observations may be interpreted to suggest that the action of THs on the early bovine embryo is exerted mainly during embryo culture rather than during oocyte maturation. This is in agreement with an earlier study in a murine model, where TH supplementation had no effect on oocyte maturation (Cecconi et al., 1999) . Conversely, in amphibians TH supplementation has been shown to positively impact the oocyte maturation phase, and the phenomenon has been demonstrated both in vitro and in vivo (Detlaf and Davydova, 1974; Mylonas et al., 1998) . Furthermore, there is no agreement on the impact the THs have in non-vertebrate species (Vandorpe et al., 1990) . It is feasible that TH supplementation has little or no effect on the maturation phase in bovine and murine models, but it is clear that the role THs play in embryo development across species may vary and is certainly worthy of additional investigations.
One possible reason why THs had no effect on embryo development following supplementation of IVM media only is that during the entire in-vitro embryo production system there was insufficient incubation time for genomic events to occur. TH-influenced transcriptional effects are time dependent (Goglia et al., 2001 (Goglia et al., , 2002 , and it is known that maximal effects of THs are often not observed until 3 days after continuous administration in vitro (Goglia et al., 1999) . Although our protocol involved a 20-h incubation period during the maturation phase, TH exposure was discontinuous as a series of washes prior to fertilization were carried out. Secondly, the elements necessary for genomic actions including transcription factors might not be available at that developmental stage in bovine embryos. THs exert their genomic effects via thyroid hormone receptors (Sap et al., 1986; Weinberger et al., 1986) , and TR mRNAs have been detected in Xenopus and human oocytes (Zhang et al., 1997; Wong et al., 1998) . However, there is presently no evidence to unequivocally support the expression of TRs during oocyte maturation and EED in vertebrate species.
Production of competent embryos is the ultimate goal of ARTs to maximize the probability of implantation and ensuing embryonic/ fetal development (Farin et al., 1995) . In the present study, there was a significant increase in total cell number of blastocysts from TH-treated groups as compared with controls. Moreover, the average percentage of apoptotic cells was lower in the TH treated group. As TH exposure during EED resulted in greater total cell number and lower apoptotic rates in bovine blastocysts, this could improve the likelihood of pregnancy following the transfer to the synchronized recipients.
Although the reduction in the rate of cell apoptosis may have been considered beneficial for the embryo, our understanding of the role of apoptosis in EED is still limited. Some studies have demonstrated a role for THs in the induction and inhibition of programmed cell death through mitochondrial pathways, both in vivo and in vitro (Shi et al., 2001; Asahara et al., 2003; Laoag-Fernandez et al., 2004) . It has been demonstrated by several authors that the apoptotic rate in embryonic cells are greater for in-vitro than for in-vivo produced embryos (Matwee et al., 2000; Betts and King, 2001; Sagirkaya et al., 2007) . Further investigation into TH action on apoptotic pathways in the early embryo is necessary.
The blastocysts developed after TH supplementation exhibited greater viability rate compared with controls, as evidenced by re-expansion of the blastocoelic cavity within 24 h post-thawing. Also, a higher hatching rate was observed in the treated group at 72 h post-thawing, and this could be interpreted as greater developmental competence. These findings were the first to show a positive impact of THs on embryo viability and tolerance to cryopreservation. If we considered cryopreservation a stressor, THs may have alleviated the negative effects of freezing by assisting in blastocyst recovery from the cryopreservation shock, which likely required additional stored energy in the form of ATP. Therefore, a function of THs in the supplemented group of embryos may have included the maintenance of energy expenditure. Assessment of blastocyst ATP content pre-and post-cryopreservation may allow for more complete characterization of that role of THs in post-cryopreservation embryo status. Needless to say, subsequent embryo transfer of cryopreserved TH-treated embryos would allow us to further evaluate the effect of THs on the conservation of embryo competency following freezing.
In summary, the present study has demonstrated a clear positive effect of TH supplementation on the early bovine embryo development in vitro, with the blastocyst formation and hatching rates significantly increased after exposure to THs. The supplementation of IVC media alone was able to produce these effects. In addition, embryo quality and post-cryopreservation developmental capacity were also improved. Collectively, these results provide evidence that TH supplementation would likely help optimize currently used in-vitro embryo production media, enhance efficiency of ARTs and help combat the obstacles obviating the applications of assisted reproductive methods in many mammalian species, including humans. The limitations of this study should serve as necessary departure points for future experiments. First, the absence of a dose-response curve for individual hormones requires that this relationship be better defined. Several investigators have suggested the hatching process requires activation of a series of proteolytic enzymes mediated by THs (Sutovsky et al., 2001) . Therefore, future studies should also consider TH impact on blastocyst proteolytic pathways to further elucidate the underlying mechanisms of these hormones. It should also be noted that although this study has shown significant increases in blastocyst rate and post-cryopreservation survival rate, the fate of embryos developed by this protocol has yet to be ascertained. Furthermore, how THs affect the normal fetal development must be studied using animals' models so that we may more accurately define the markers of embryo variability and fate, including implantation and the entire post-implantation development. To further characterize the mechanism behind TH effects during EED, thyroid hormone receptor expression in oocytes and developing preimplantation embryos should be examined in vivo and in vitro. As current human IVM/IVF media are serum free and devoid of endocrine factors including THs, the supplementation of media used in human ARTs may enhance the efficiency of in-vitro embryo production.
